Cargando…

Profiling beneficial and potential adverse effects of MeCP2 overexpression in a hypomorphic Rett syndrome mouse model

De novo loss‐of‐function mutations in methyl‐CpG‐binding protein 2 (MeCP2) lead to the neurodevelopmental disorder Rett syndrome (RTT). Despite promising results from strategies aimed at increasing MeCP2 levels, additional studies exploring how hypomorphic MeCP2 mutations impact the therapeutic wind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vermudez, Sheryl Anne D., Gogliotti, Rocco G., Arthur, Bright, Buch, Aditi, Morales, Clarissa, Moxley, Yuta, Rajpal, Hemangi, Conn, P. Jeffrey, Niswender, Colleen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599502/ https://www.ncbi.nlm.nih.gov/pubmed/34002468 http://dx.doi.org/10.1111/gbb.12752

Ejemplares similares

Clinical and Preclinical Evidence for M(1) Muscarinic Acetylcholine Receptor Potentiation as a Therapeutic Approach for Rett Syndrome
por: Smith, Mackenzie, et al.
Publicado: (2022)

Optimized Administration of the M(4) PAM VU0467154 Demonstrates Broad Efficacy, but Limited Effective Concentrations in Mecp2(+/–) Mice
por: Cikowski, Jakub, et al.
Publicado: (2022)

Rett Syndrome and MECP2 Duplication Syndrome: Disorders of MeCP2 Dosage
por: Collins, Bridget E, et al.
Publicado: (2022)

Structural investigation of Rett-inducing MeCP2 mutations()
por: Spiga, Ottavia, et al.
Publicado: (2018)

Rett mutations attenuate phase separation of MeCP2
por: Fan, Chunyan, et al.
Publicado: (2020)

The Molecular Functions of MeCP2 in Rett Syndrome Pathology
por: Sharifi, Osman, et al.
Publicado: (2021)

MeCP2: The Genetic Driver of Rett Syndrome Epigenetics
por: Good, Katrina V., et al.
Publicado: (2021)

MeCP2 Deficiency in Neuroglia: New Progress in the Pathogenesis of Rett Syndrome
por: Jin, Xu-Rui, et al.
Publicado: (2017)

Glial Dysfunction in MeCP2 Deficiency Models: Implications for Rett Syndrome
por: Kahanovitch, Uri, et al.
Publicado: (2019)

MeCP2 mutations: progress towards understanding and treating Rett syndrome
por: Shah, Ruth R., et al.
Publicado: (2017)

MeCP2 in the regulation of neural activity: Rett syndrome pathophysiological perspectives
por: Cuddapah, Vishnu Anand, et al.
Publicado: (2015)

MeCP2_e2 partially compensates for lack of MeCP2_e1: A male case of Rett syndrome
por: Takeguchi, Ryo, et al.
Publicado: (2019)

A novel DNA-binding feature of MeCP2 contributes to Rett syndrome
por: Xu, Xin, et al.
Publicado: (2013)

Rett Syndrome Mutant Neural Cells Lacks MeCP2 Immunoreactive Bands
por: Bueno, Carlos, et al.
Publicado: (2016)

Radically truncated MeCP2 rescues Rett syndrome-like neurological defects
por: Tillotson, Rebekah, et al.
Publicado: (2017)

MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome
por: Tai, Derek J. C., et al.
Publicado: (2016)

Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice
por: Heckman, Laura Dean, et al.
Publicado: (2014)

Characterization of the MeCP2(R168X) Knockin Mouse Model for Rett Syndrome
por: Wegener, Eike, et al.
Publicado: (2014)

Manipulations of MeCP2 in glutamatergic neurons highlight their contributions to Rett and other neurological disorders
por: Meng, Xiangling, et al.
Publicado: (2016)

Biotin tagging of MeCP2 in mice reveals contextual insights into the Rett syndrome transcriptome
por: Johnson, B.S., et al.
Publicado: (2017)

Molecular Context-Dependent Effects Induced by Rett Syndrome-Associated Mutations in MeCP2
por: Ortega-Alarcon, David, et al.
Publicado: (2020)

Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease
por: Pejhan, Shervin, et al.
Publicado: (2021)

Cell cloning-based transcriptome analysis in Rett patients: relevance to the pathogenesis of Rett syndrome of new human MeCP2 target genes
por: Nectoux, J, et al.
Publicado: (2010)

Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients
por: Lilja, Tobias, et al.
Publicado: (2013)

Structural, Dynamical, and Energetical Consequences of Rett Syndrome Mutation R133C in MeCP2
por: Kucukkal, Tugba G., et al.
Publicado: (2015)

Loss of MeCP2 in the rat models regression, impaired sociability and transcriptional deficits of Rett syndrome
por: Veeraragavan, Surabi, et al.
Publicado: (2016)

Interplay of LIS1 and MeCP2: Interactions and Implications With the Neurodevelopmental Disorders Lissencephaly and Rett Syndrome
por: Keidar, Liraz, et al.
Publicado: (2019)

Rett syndrome linked to defects in forming the MeCP2/Rbfox/LASR complex in mouse models
por: Jiang, Yan, et al.
Publicado: (2021)

Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2
por: Chen, Xiaoying, et al.
Publicado: (2020)

The relationship of Rett syndrome and MECP2 disorders to autism
por: Neul, Jeffrey Lorenz
Publicado: (2012)

Multimodal Neuroimaging in Rett Syndrome With MECP2 Mutation
por: Kong, Yu, et al.
Publicado: (2022)

Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets
por: Jordan, ChaRandle, et al.
Publicado: (2007)

Linking Epigenetics to Human Disease and Rett Syndrome: The Emerging Novel and Challenging Concepts in MeCP2 Research
por: Zachariah, Robby Mathew, et al.
Publicado: (2012)

MeCP2 deficiency results in robust Rett-like behavioural and motor deficits in male and female rats
por: Patterson, Kelsey C., et al.
Publicado: (2016)

MeCP2 deficiency results in robust Rett-like behavioural and motor deficits in male and female rats
por: Patterson, Kelsey C., et al.
Publicado: (2016)

Fluoxetine increases brain MeCP2 immuno-positive cells in a female Mecp2 heterozygous mouse model of Rett syndrome through endogenous serotonin
por: Villani, Claudia, et al.
Publicado: (2021)

Spectrum of MECP2 mutations in Vietnamese patients with RETT syndrome
por: Le Thi Thanh, Huong, et al.
Publicado: (2018)

Rett Syndrome Mutation MeCP2 T158A Disrupts DNA Binding, Protein Stability and ERP Responses
por: Goffin, Darren, et al.
Publicado: (2011)

Targeted manipulation of heterochromatin rescues MeCP2 Rett mutants and re-establishes higher order chromatin organization
por: Casas-Delucchi, Corella S., et al.
Publicado: (2012)

Loss of MeCP2 Causes Urological Dysfunction and Contributes to Death by Kidney Failure in Mouse Models of Rett Syndrome
por: Ward, Christopher S., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_he48b92fa8c26hgfb92hresea1